[go: up one dir, main page]

FR2922450B1 - USE OF LACTIC ACID BACTERIA FOR THE PREVENTION AND / OR TREATMENT OF SKIN CONDITIONS - Google Patents

USE OF LACTIC ACID BACTERIA FOR THE PREVENTION AND / OR TREATMENT OF SKIN CONDITIONS

Info

Publication number
FR2922450B1
FR2922450B1 FR0707324A FR0707324A FR2922450B1 FR 2922450 B1 FR2922450 B1 FR 2922450B1 FR 0707324 A FR0707324 A FR 0707324A FR 0707324 A FR0707324 A FR 0707324A FR 2922450 B1 FR2922450 B1 FR 2922450B1
Authority
FR
France
Prior art keywords
prevention
treatment
lactic acid
acid bacteria
skin conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0707324A
Other languages
French (fr)
Other versions
FR2922450A1 (en
Inventor
Henri Durand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lallemand SA
Original Assignee
Lallemand SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lallemand SA filed Critical Lallemand SA
Priority to FR0707324A priority Critical patent/FR2922450B1/en
Priority to PCT/IB2008/054273 priority patent/WO2009050677A2/en
Publication of FR2922450A1 publication Critical patent/FR2922450A1/en
Application granted granted Critical
Publication of FR2922450B1 publication Critical patent/FR2922450B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0707324A 2007-10-19 2007-10-19 USE OF LACTIC ACID BACTERIA FOR THE PREVENTION AND / OR TREATMENT OF SKIN CONDITIONS Expired - Fee Related FR2922450B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0707324A FR2922450B1 (en) 2007-10-19 2007-10-19 USE OF LACTIC ACID BACTERIA FOR THE PREVENTION AND / OR TREATMENT OF SKIN CONDITIONS
PCT/IB2008/054273 WO2009050677A2 (en) 2007-10-19 2008-10-17 Use of lactic bacteria for the prophylaxis and/or treatment of skin diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0707324A FR2922450B1 (en) 2007-10-19 2007-10-19 USE OF LACTIC ACID BACTERIA FOR THE PREVENTION AND / OR TREATMENT OF SKIN CONDITIONS

Publications (2)

Publication Number Publication Date
FR2922450A1 FR2922450A1 (en) 2009-04-24
FR2922450B1 true FR2922450B1 (en) 2014-06-13

Family

ID=39560857

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0707324A Expired - Fee Related FR2922450B1 (en) 2007-10-19 2007-10-19 USE OF LACTIC ACID BACTERIA FOR THE PREVENTION AND / OR TREATMENT OF SKIN CONDITIONS

Country Status (2)

Country Link
FR (1) FR2922450B1 (en)
WO (1) WO2009050677A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP3091861A1 (en) * 2013-11-25 2016-11-16 Nestec S.A. Heat-treated formulation of bifidobacterium lactis ncc 2818 reduces allergic manifestations
WO2017173241A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
EP3544575A1 (en) 2016-11-23 2019-10-02 GOJO Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2019197672A1 (en) 2018-04-13 2019-10-17 Danstar Ferment Ag Use of probiotic bacteria as active ingredient producing a skin-tightening effect
US12083152B2 (en) 2018-09-26 2024-09-10 Meiji Co., Ltd. Agent for improving mitochondrial function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2837711B1 (en) * 2002-03-28 2005-05-06 Agronomique Inst Nat Rech USE OF LACTOBACILLUS FARCIMINIS FOR THE PREVENTION OR TREATMENT OF DIGESTIVE DISEASES
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
GB0513556D0 (en) * 2005-07-01 2005-08-10 Matforsk As Product
PL1951272T3 (en) * 2005-10-06 2016-12-30 Use of lactobacillus for treatment of virus infections
WO2008031438A2 (en) * 2006-09-13 2008-03-20 Region Hovedstaden V/Gentofte Hospital Treatment of asthma, eczema and/or allergy using non-pathogenic organisms

Also Published As

Publication number Publication date
FR2922450A1 (en) 2009-04-24
WO2009050677A3 (en) 2010-01-21
WO2009050677A2 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
EP2528603A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS
EP2365941A4 (en) TREATMENT OF SOLUTIONS OR WASTEWATER
EP2921138A4 (en) IMPLANT SYSTEM FOR THE TREATMENT OF SINUSITIS OR ALLERGIC RHINITIS
EP2651407A4 (en) 3-METHANESULFONYLPROPIONITRILE FOR THE TREATMENT OF INFLAMMATION AND PAIN
EP2184997A4 (en) DIAGNOSTIC AND TREATMENT METHODS FOR CHARACTERIZING BACTERIAL MICROBIOTES IN SKIN DISORDERS
EP2300035A4 (en) MIXED AGONISTS GIP-BASED FOR THE TREATMENT OF METABOLISM DISEASES AND FAT HEAVY
EP2464362A4 (en) PROBIOTIC PREPARATION FOR THE PREVENTION OR TREATMENT OF DENTRICULAR DARM DISEASES IN DOGS
EP2483417A4 (en) DIAGNOSTIC AND TREATMENT METHODS FOR ENCEPHALITY OR EPILEPSY
EP2903597A4 (en) USE OF MICROVESICLES IN THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF DISEASES AND MEDICAL CONDITIONS
PT2318033T (en) Compositions for the treatment of pain and/or inflamation
FR2922450B1 (en) USE OF LACTIC ACID BACTERIA FOR THE PREVENTION AND / OR TREATMENT OF SKIN CONDITIONS
EP2217576A4 (en) BENZODIAZEPINONE COMPOUNDS USEFUL IN THE TREATMENT OF SKIN CONDITIONS
EP2651439A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF HUMAN ADENOVIRUS INFECTION 36
FR2907011B1 (en) USE OF CITRULLINE FOR THE TREATMENT OF DENUTRITION CONDITIONS
EP2723902A4 (en) TREATMENT AND DIAGNOSIS OF EPIGENETIC DISORDERS AND CONDITIONS
FR2919501B1 (en) USE OF HESPERIDINE OR ONE OF ITS DERIVATIVES FOR THE PREVENTION AND / OR TREATMENT OF RELEASED SKINS
EP2498603A4 (en) USE OF ANTIBACTERIAL AGENTS FOR THE TREATMENT OF EPITHELIAL DISORDERS
FR2882654B1 (en) USE OF DIOSMETIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF THROMBOTIC DISEASES
EP2702992A4 (en) USE OF MELATONIN FOR THE TREATMENT AND / OR PREVENTION OF MUCOSITIS
EP2603609A4 (en) TREATMENT AND DIAGNOSIS OF EPIGENETIC DISORDERS AND DISORDERS
EP2640408A4 (en) KERATINIC COMPOSITIONS FOR THE TREATMENT OF BONE INJURY OR INJURY
FR2919187B1 (en) USE OF YEAST SKIN FOR THE TREATMENT AND / OR PREVENTION OF HYPERINSULINEMIA.
EP2382206A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN AND OTHER DISEASES
HK1143756A1 (en) Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain
EP2361317A4 (en) USE OF EIF3M FOR THE DIAGNOSIS AND TREATMENT OF CANCER

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20230606